$28.5B
$439,000
0.01% of portfolio
21,471
Q3 2024
Reduced 12.08%
$207B
$637,000
0.01% of portfolio
1,288
Q3 2024
Reduced 0.62%
$101B
$479,000
0.01% of portfolio
6,148
Q3 2024
Reduced 31.15%
$0
$306,000
0.0% of portfolio
2,107
Q2 2024
Reduced 3.44%
$2.96B
$273,000
0.0% of portfolio
2,600
Q3 2022
New
$0
$202,000
0.0% of portfolio
3,479
Q3 2024
New
$0
$310,000
0.0% of portfolio
3,162
Q3 2024
New
$80.7B
$281,000
0.0% of portfolio
813
Q2 2024
Reduced 0.97%
$6.39B
$234,000
0.0% of portfolio
2,102
Q3 2024
New
$26.8B
$290,000
0.0% of portfolio
3,025
Q3 2024
Added 0.83%
$16.9B
$244,000
0.0% of portfolio
2,450
Q4 2023
Reduced 20.71%
$0
$274,000
0.0% of portfolio
1,118
Q1 2024
New
$130B
$292,000
0.0% of portfolio
4,715
Q2 2023
Added 4.57%
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 31.53%
$28.9B
$220,000
0.0% of portfolio
7,600
Q2 2023
Reduced 5.35%
$38.3B
$241,000
0.0% of portfolio
7,270
Q2 2024
Added 100.0%
$6.16B
$219,000
0.0% of portfolio
6,502
Q3 2024
Reduced 1.22%
$0
$123,000
0.0% of portfolio
11,200
Q3 2024
Reduced 2.61%
$38.2B
$364,000
0.0% of portfolio
2,044
Q2 2024
Reduced 8.09%
$0
$266,000
0.0% of portfolio
2,178
Q3 2024
Reduced 18.67%
$39.8B
$265,000
0.0% of portfolio
1,789
Q1 2024
New
$15.5B
$130,000
0.0% of portfolio
11,500
Q4 2022
New
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 20.94%
$0
$349,000
0.0% of portfolio
1,918
Q3 2024
Reduced 9.44%
$0
$322,000
0.0% of portfolio
1,398
Q1 2024
Added 200.0%
$89.5B
$274,000
0.0% of portfolio
355
Q2 2024
Reduced 24.47%
$24.3B
$314,000
0.0% of portfolio
9,028
Q2 2024
Reduced 28.56%
$1.46B
$262,000
0.0% of portfolio
2,100
Q1 2024
Reduced 20.09%
-
$0
0.0% of portfolio
-
Q3 2024
Added 0.71%
-
$0
0.0% of portfolio
-
Q3 2023
New
$89.9B
$253,000
0.0% of portfolio
1,666
Q2 2024
Reduced 39.57%
$69.1B
$267,000
0.0% of portfolio
1,330
Q3 2024
Added 15.95%
$0
$385,000
0.0% of portfolio
911
Q1 2024
Reduced 12.4%
$45.3B
$359,000
0.0% of portfolio
2,650
Q3 2023
Reduced 14.38%
$47.1B
$366,000
0.0% of portfolio
4,112
Q3 2024
Reduced 7.28%
$50.7B
$376,000
0.0% of portfolio
4,131
Q3 2024
Added 3.28%
$0
$284,000
0.0% of portfolio
4,219
Q3 2024
New
$0
$324,000
0.0% of portfolio
7,122
Q2 2024
Reduced 0.04%
$24.4B
$244,000
0.0% of portfolio
567
Q2 2024
New
$610M
$371,000
0.0% of portfolio
1,525
Q4 2020
Added 1.67%
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 23.73%
$10.5B
$351,000
0.0% of portfolio
9,119
Q3 2024
Added 18.0%
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 0.16%
Ginkgo Bioworks Holdings Inc
-
$0
0.0% of portfolio
-
Q3 2024
New
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 4.71%
Ge Healthcare Technologies I
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 4.12%
$10.9B
$251,000
0.0% of portfolio
2,375
Q3 2024
New
$3.18B
$367,000
0.0% of portfolio
8,000
Q1 2023
New
$150B
$288,000
0.0% of portfolio
4,459
Q3 2024
Added 0.81%
$0
$219,000
0.0% of portfolio
3,962
Q3 2024
New